NMX

Established in 2014, NMX Research & Solutions is an innovative CRO specializing in biophysical screening for Fragment-Based Lead Discovery (FBLD). Our streamlined biophysics platform pairs advanced NMR techniques with orthogonal biophysical methods, curated libraries, biochemical assays, and virtual screens. Tailored towards biotechnology and pharmaceutical clients, NMX confidently delivers flexible, impactful solutions to drive your drug discovery objectives forward at any stage of development. NMX goes beyond the standard Contract Research Organization – we are your trusted Contract Research Partner (CRP)!